Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC
Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC have?
Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC has 80 citations in the OpenAlex counts ScholarIQ stores.
When was Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC published?
Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC has 2025 year in the ScholarIQ index.
What is the open-access status of Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC?
Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC has closed oa status in the ScholarIQ index.
What is the DOI of Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC?
The DOI for Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC is on the source record.
What is the PMID of Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC?
The PMID for Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC is on the source record.
What is the OpenAlex record for Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC?
The OpenAlex for Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC is on the source record.